BOCCHIA MONICA | Professor page

Sicuranza, A., Pacelli, P., Santoni, A., Raspadori, D., Bocchia, M. (2025). Reply to “Peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia and tyrosine kinase inhibitor response: Questions remain!”. CANCER, 131(24) [10.1002/cncr.70214]. - view more
Vitale, A., Leone, F., Caggiano, V., Hinojosa-Azaola, A., Martín-Nares, E., Guaracha-Basañez, G.A., et al. (2025). Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network. FRONTIERS IN PHARMACOLOGY, 16 [10.3389/fphar.2025.1539756]. - view more
Mutti, S., Cavalleri, A., Sicuranza, A., Pacelli, P., Ielo, C., Paolini, L., et al. (2025). Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML). STEM CELLS TRANSLATIONAL MEDICINE, 14(12) [10.1093/stcltm/szaf062]. - view more
Caroni, F., Sammartano, V., Pacelli, P., Sicuranza, A., Malchiodi, M., Dragomir, A., et al. (2025). Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies. PHARMACEUTICALS, 18(2) [10.3390/ph18020159]. - view more
Vitale, A., Sbalchiero, J., Caggiano, V., Lazzi, S., Tharwat, S., Fotis, L., et al. (2025). Development and implementation of the International AIDA Network Castleman’s disease registry. FRONTIERS IN MEDICINE, 12 [10.3389/fmed.2025.1579182]. - view more